Envoy Medical (Envoy Medical) Debt-to-Equity : -0.32 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Debt-to-Equity?

Envoy Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.16 Mil. Envoy Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.40 Mil. Envoy Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-1.76 Mil. Envoy Medical's debt to equity for the quarter that ended in Dec. 2023 was -0.32.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Envoy Medical's Debt-to-Equity or its related term are showing as below:

COCH' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.95 Med: -0.52 Max: -0.32
Current: -0.32

During the past 3 years, the highest Debt-to-Equity Ratio of Envoy Medical was -0.32. The lowest was -0.95. And the median was -0.52.

COCH's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs COCH: -0.32

Envoy Medical Debt-to-Equity Historical Data

The historical data trend for Envoy Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Debt-to-Equity Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Equity

-0.52

-0.95

-0.32

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			N/A	-0.95	-0.71	0.09	-0.32

Competitive Comparison of Envoy Medical's Debt-to-Equity

For the Medical Devices subindustry, Envoy Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Envoy Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Envoy Medical's Debt-to-Equity falls into.

Envoy Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Envoy Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.158	+	0.404)	/	-1.762
	=	-0.32

Envoy Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.158	+	0.404)	/	-1.762
	=	-0.32

Envoy Medical (NAS:COCH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Envoy Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Envoy Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.